within Pharmacolibrary.Drugs.ATC.G;

model G01AF04_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.25,
    Cl             = 2.05e-05,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.036,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0006666666666666666,
    Tlag           = 1200
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G01AF04_1</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Miconazole is an imidazole antifungal agent used to treat dermatophytic and yeast infections of the skin, mouth, and vagina. It acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes. Miconazole is approved for topical and some mucosal infections and is widely used today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in healthy adults following single oral administration of miconazole tablets.</p><h4>References</h4><ol><li><p>Hynninen, VV, et al., &amp; Laine, K (2009). Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib. <i>European journal of clinical pharmacology</i> 65(1) 89–95. DOI:<a href=&quot;https://doi.org/10.1007/s00228-008-0556-9&quot;>10.1007/s00228-008-0556-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18777173/&quot;>https://pubmed.ncbi.nlm.nih.gov/18777173</a></p></li><li><p>Grönlund, J, et al., &amp; Laine, K (2011). Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4. <i>Antimicrobial agents and chemotherapy</i> 55(3) 1063–1067. DOI:<a href=&quot;https://doi.org/10.1128/AAC.01242-10&quot;>10.1128/AAC.01242-10</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21173180/&quot;>https://pubmed.ncbi.nlm.nih.gov/21173180</a></p></li><li><p>Cardot, JM, et al., &amp; Aiache, JM (2004). Comparison of the pharmacokinetics of miconazole after administration via a bioadhesive slow release tablet and an oral gel to healthy male and female subjects. <i>British journal of clinical pharmacology</i> 58(4) 345–351. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.2004.02154.x&quot;>10.1111/j.1365-2125.2004.02154.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15373926/&quot;>https://pubmed.ncbi.nlm.nih.gov/15373926</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G01AF04_1;
